Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps

Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking strategic alternatives for the business. Prospective buyers can pick up Pear’s FDA-cleared products for substance use disorder, opioid use disorder, and insomnia.

Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps - MedCity News